+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genotyping Market Size, Share & Trends Analysis Report By Product, By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5595799
Description Jump to:
The global genotyping market size is anticipated to reach USD $46.53 billion by 2030, registering a CAGR of 14.59% over the forecast period. Factors such as the rising prevalence of genetic diseases, rising awareness and research for personalized medicine, and increasing R&D funding for genomics research is expected to contribute to this growth.

Governments in multiple countries are taking various initiatives to provide support and funding to research organizations for personalized medicine, and genotyping research is anticipated to drive the market. For instance, in August 2019, NIH funded USD 4.6 million initial grants to Color, a health technology company, for precision medicine initiatives and development. Similarly, in 2018, the Government of Australia launched the Australian Genomics Health Futures Mission initiative. The government will provide USD 500 million over a period of 10 years for this mission, and the funding will be sourced from Medical Research Future Fund to improve the testing and diagnosis of genetic diseases and for the development of personalized medicine.

An increase in the prevalence of diseases such as cancer, Alzheimer’s disease, and Parkinson’s disease is another factor that is anticipated to drive demand for genotyping-based diagnostic testing. For instance, Roche has products such as Cobas HCV GT products for cervical cancer diagnosis. Additionally, 23&Me provides genetic testing for medical conditions, such as Parkinson's disease and Alzheimer’s disease.

Failed clinical trials cost companies millions of dollars and therefore companies group patients according to their genotypes. Single Nucleotide Polymorphisms (SNP) based genotyping is increasingly being used in pharmacogenomics to study the effect of genetic variations on the difference in response to therapeutics. Genotyping-based treatment administration also helps in overall cost savings.

The COVID-19 pandemic increased the demand for genotyping-based research activities for the development of COVID diagnostics, vaccines, and therapeutics. Many companies, including Qiagen and Thermo Fisher Scientific, have now launched COVID-19 genotyping kits as a result of the growing demand.

Key players leverage strategic partnerships and new product launches to increase their product offerings. For instance, in January 2020, Illumina and Roche entered into a partnership for improving patient access to oncology genomic testing by assay development. Similarly, in June 2021, the Center for Aquaculture Technologies collaborated with Neogen Corporation to provide high-quality genotyping services tailored to aquaculture producers’ specific demands.

Genotyping Market Report Highlights

  • The reagents & kit segment accounted for the largest share of 61.77% in the market in 2022. This is attributed to increased demand for genetic testing, increased R&D spending, and increased genotyping testing volumes
  • PCR segment dominated the market in 2022, whereas sequencing is expected to expand at the highest CAGR during the forecast period. This is due to advantages of the technique, such as low cost per sample, reduced bias as compared to arrays, comparative analysis across samples with no reference genome
  • Pharmacogenomics is estimated to be the fastest-growing application segment during the forecast period due to increased usage of genotyping in drug development to reduce attrition of products in clinical development
  • North America accounted for the largest market share in 2022, owing to proactive government measures, high disease prevalence, technological advancements, and advanced healthcare infrastructure

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Prevalence Of Genetic And Other Target Diseases
3.2.1.2. Increasing Focus On Development Of Targeted Drugs And Personalized Medicine
3.2.1.3. Technological Advancements In Genotyping Techniques
3.2.1.4. Increase In Funding In Genomics
3.2.2. Market Restraint Analysis
3.2.2.1. Lack Of Skilled Labor
3.2.2.2. Ambiguous Reimbursement Policies
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Genotyping Market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.3. Reagents & Kits
4.3.1. Reagents & Kits Market, 2018 - 2030 (USD Million)
4.4. Software and Services
4.4.1. Software and Services Market, 2018 - 2030 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Genotyping Market: Technology Movement Analysis
5.2. PCR
5.2.1. PCR Market, 2018 - 2030 (USD Million)
5.3. Capillary Electrophoresis
5.3.1. Capillary Electrophoresis Market, 2018 - 2030 (USD Million)
5.4. Microarrays
5.4.1. Microarrays Market, 2018 - 2030 (USD Million)
5.5. Sequencing
5.5.1. Sequencing Market, 2018 - 2030 (USD Million)
5.6. Mass Spectrometry
5.6.1. Mass Spectrometry Market, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Other Technologies Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Genotyping Market: Application Movement Analysis
6.2. Pharmacogenomics
6.2.1. Pharmacogenomics Market, 2018 - 2030 (USD Million)
6.3. Diagnostics and Personalized Medicine
6.3.1. Diagnostics and Personalized Medicine Market, 2018 - 2030 (USD Million)
6.4. Agricultural Biotechnology
6.4.1. Agricultural Biotechnology Market, 2018 - 2030 (USD Million)
6.5. Animal Genetics
6.5.1. Animal Genetics Market, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Other Application Market, 2018 - 2030 (USD Million)
Chapter 7. End-Use Business Analysis
7.1. Genotyping Market: End-use Movement Analysis
7.2. Pharmaceutical and Biopharmaceutical Companies
7.2.1. Pharmaceutical and Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
7.3. Diagnostics and Research Laboratories
7.3.1. Diagnostics and Research Laboratories Market, 2018 - 2030 (USD Million)
7.4. Academic Institutes
7.4.1. Academic Institutes Market, 2018 - 2030 (USD Million)
7.5. Others
7.5.1. Other End-use Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Genotyping Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America Genotyping Market, 2018 - 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. U.S. Genotyping Market, 2018 - 2030 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Canada Genotyping Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. SWOT Analysis
8.3.2. Europe Genotyping Market, 2018 - 2030 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. UK Genotyping Market, 2018 - 2030 (USD Million)
8.3.4. Germany
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Germany Genotyping Market, 2018 - 2030 (USD Million)
8.3.5. France
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. France Genotyping Market, 2018 - 2030 (USD Million)
8.3.6. Italy
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Italy Genotyping Market, 2018 - 2030 (USD Million)
8.3.7. Spain
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Spain Genotyping Market, 2018 - 2030 (USD Million)
8.3.8. Denmark
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Denmark Genotyping Market, 2018 - 2030 (USD Million)
8.3.9. Sweden
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Sweden Genotyping Market, 2018 - 2030 (USD Million)
8.3.10. Norway
8.3.10.1. Key Country Dynamics
8.3.10.2. Target Disease Prevalence
8.3.10.3. Competitive Scenario
8.3.10.4. Regulatory Framework
8.3.10.5. Norway Genotyping Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. SWOT Analysis
8.4.2. Asia Pacific Genotyping Market, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. Japan Genotyping Market, 2018 - 2030 (USD Million)
8.4.4. China
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. China Genotyping Market, 2018 - 2030 (USD Million)
8.4.5. India
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. India Genotyping Market, 2018 - 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Australia Genotyping Market, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. Thailand Genotyping Market, 2018 - 2030 (USD Million)
8.4.8. South Korea
8.4.8.1. Key Country Dynamics
8.4.8.2. Target Disease Prevalence
8.4.8.3. Competitive Scenario
8.4.8.4. Regulatory Framework
8.4.8.5. South Korea Genotyping Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. SWOT Analysis
8.5.2. Latin America Genotyping Market, 2018 - 2030 (USD Million)
8.5.3. Brazil
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Brazil Genotyping Market, 2018 - 2030 (USD Million)
8.5.4. Mexico
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Regulatory Framework
8.5.4.5. Mexico Genotyping Market, 2018 - 2030 (USD Million)
8.5.5. Argentina
8.5.5.1. Key Country Dynamics
8.5.5.2. Target Disease Prevalence
8.5.5.3. Competitive Scenario
8.5.5.4. Regulatory Framework
8.5.5.5. Argentina Genotyping Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. SWOT Analysis
8.6.2. MEA Genotyping Market, 2018 - 2030 (USD Million)
8.6.3. South Africa
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. South Africa Genotyping Market, 2018 - 2030 (USD Million)
8.6.4. Saudi Arabia
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. Saudi Arabia Genotyping Market, 2018 - 2030 (USD Million)
8.6.5. UAE
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. UAE Genotyping Market, 2018 - 2030 (USD Million)
8.6.6. Kuwait
8.6.6.1. Key Country Dynamics
8.6.6.2. Target Disease Prevalence
8.6.6.3. Competitive Scenario
8.6.6.4. Regulatory Framework
8.6.6.5. Kuwait Genotyping Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific, Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Illumina, Inc.
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. QIAGEN
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. F. Hoffmann-La Roche Ltd.
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Fluidigm Corporation
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Danaher Corporation
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Agilent Technologies
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Eurofins Scientific Inc.
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. GE Healthcare Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Bio-Rad Laboratories Inc.
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 3 North America genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 4 North America genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 5 North America genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 7 U.S. genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 9 U.S. genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 10 Canada genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 11 Canada genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 12 Canada genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 13 Canada genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 14 Europe genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 15 Europe genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 16 Europe genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 17 Europe genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 18 UK genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 19 UK genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 20 UK genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 21 UK genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 22 Germany genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 23 Germany genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 24 Germany genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 25 Germany genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 26 France genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 27 France genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 28 France genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 29 France genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 30 Italy genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 31 Italy genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 32 Italy genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 33 Italy genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 34 Spain genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 35 Spain genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 36 Spain genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 37 Spain genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 38 Denmark genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 39 Denmark genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 40 Denmark genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 41 Denmark genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 42 Sweden genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 43 Sweden genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 44 Sweden genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 45 Sweden genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 46 Norway genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 47 Norway genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 48 Norway genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 49 Norway genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 50 Asia Pacific genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 51 Asia Pacific genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 52 Asia Pacific genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 53 Asia Pacific genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 54 Japan genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 55 Japan genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 56 Japan genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 57 Japan genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 58 China genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 59 China genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 60 China genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 61 China genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 62 India genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 63 India genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 64 India genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 65 India genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 66 Australia genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 67 Australia genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 68 Australia genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 69 Australia genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 70 Thailand genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 71 Thailand genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 72 Thailand genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 73 Thailand genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 74 South Korea genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 75 South Korea genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 76 South Korea genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 77 South Korea genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 78 Latin America genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 79 Latin America genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 80 Latin America genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 81 Latin America genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 82 Brazil genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 83 Brazil genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 84 Brazil genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 85 Brazil genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 86 Mexico genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 87 Mexico genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 88 Mexico genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 89 Mexico genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 90 Argentina genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 91 Argentina genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 92 Argentina genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 93 Argentina genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 94 MEA genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 95 MEA genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 96 MEA genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 97 MEA genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 98 South Africa genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 99 South Africa genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 100 South Africa genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 101 South Africa genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 102 Saudi Arabia genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 103 Saudi Arabia genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 104 Saudi Arabia genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 105 Saudi Arabia genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 106 UAE genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 107 UAE genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 108 UAE genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 109 UAE genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
Table 110 Kuwait genotyping market estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 111 Kuwait genotyping market estimates and forecasts, by technology, 2018 - 2030 (USD Million)
Table 112 Kuwait genotyping market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 113 Kuwait genotyping market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Genotyping market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Genotyping product outlook: Key takeaways
Fig. 15 Genotyping market: Product movement analysis
Fig. 16 Instruments market, 2018 - 2030 (USD Million)
Fig. 17 Reagents & kits market, 2018 - 2030 (USD Million)
Fig. 18 Software and services market, 2018 - 2030 (USD Million)
Fig. 19 Genotyping technology outlook: Key takeaways
Fig. 20 Genotyping market: Technology movement analysis
Fig. 21 PCR market, 2018 - 2030 (USD Million)
Fig. 22 Capillary electrophoresis market, 2018 - 2030 (USD Million)
Fig. 23 Microarrays market, 2018 - 2030 (USD Million)
Fig. 24 Sequencing market, 2018 - 2030 (USD Million)
Fig. 25 Mass spectrometry market, 2018 - 2030 (USD Million)
Fig. 26 Other technologies market, 2018 - 2030 (USD Million)
Fig. 27 Genotyping application outlook: Key takeaways
Fig. 28 Genotyping market: Application movement analysis
Fig. 29 Diagnostics & personalized medicine market, 2018 - 2030 (USD Million)
Fig. 30 Pharmacogenomics market, 2018 - 2030 (USD Million)
Fig. 31 Agricultural biotechnology market, 2018 - 2030 (USD Million)
Fig. 32 Animal genetics market, 2018 - 2030 (USD Million)
Fig. 33 Other applications market, 2018 - 2030 (USD Million)
Fig. 34 Genotyping end-use outlook: Key takeaways
Fig. 35 Genotyping market: End-use movement analysis
Fig. 36 Pharmaceutical and biopharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 37 Diagnostics and research laboratories market, 2018 - 2030 (USD Million)
Fig. 38 Academic institutes market, 2018 - 2030 (USD Million)
Fig. 39 Other end-uses market, 2018 - 2030 (USD Million)
Fig. 40 Genotyping market: Regional outlook and key takeaways
Fig. 41 Genotyping market: Regional movement analysis
Fig. 42 North America genotyping market, 2018 - 2030 (USD Million)
Fig. 43 U.S. genotyping market, 2018 - 2030 (USD Million)
Fig. 44 Canada genotyping market, 2018 - 2030 (USD Million)
Fig. 45 Europe genotyping market, 2018 - 2030 (USD Million)
Fig. 46 Germany genotyping market, 2018 - 2030 (USD Million)
Fig. 47 UK genotyping market, 2018 - 2030 (USD Million)
Fig. 48 France genotyping market, 2018 - 2030 (USD Million)
Fig. 49 Italy genotyping market, 2018 - 2030 (USD Million)
Fig. 50 Spain genotyping market, 2018 - 2030 (USD Million)
Fig. 51 Denmark genotyping market, 2018 - 2030 (USD Million)
Fig. 52 Sweden genotyping market, 2018 - 2030 (USD Million)
Fig. 53 Norway genotyping market, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific genotyping market, 2018 - 2030 (USD Million)
Fig. 55 Japan genotyping market, 2018 - 2030 (USD Million)
Fig. 56 China genotyping market, 2018 - 2030 (USD Million)
Fig. 57 India genotyping market, 2018 - 2030 (USD Million)
Fig. 58 Australia genotyping market, 2018 - 2030 (USD Million)
Fig. 59 South Korea genotyping market, 2018 - 2030 (USD Million)
Fig. 60 Thailand genotyping market, 2018 - 2030 (USD Million)
Fig. 61 Latin America genotyping market, 2018 - 2030 (USD Million)
Fig. 62 Brazil genotyping market, 2018 - 2030 (USD Million)
Fig. 63 Mexico genotyping market, 2018 - 2030 (USD Million)
Fig. 64 Argentina genotyping market, 2018 - 2030 (USD Million)
Fig. 65 Middle East and Africa genotyping market, 2018 - 2030 (USD Million)
Fig. 66 South Africa genotyping market, 2018 - 2030 (USD Million)
Fig. 67 Saudi Arabia genotyping market, 2018 - 2030 (USD Million)
Fig. 68 UAE genotyping market, 2018 - 2030 (USD Million)
Fig. 69 Kuwait genotyping market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation
  • Danaher Corporation
  • Agilent Technologies
  • Eurofins Scientific Inc.
  • GE Healthcare Inc.
  • Bio-Rad Laboratories Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 15.09 Billion
Forecasted Market Value ( USD ) by 2030 $ 46.53 Billion
Compound Annual Growth Rate14.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Genotyping Assay Market by Offering, Technology, Sample Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Genotyping Assay Market by Offering, Technology, Sample Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Genotyping Market by Product, Technology, Application - Global Forecast 2025-2030 - Product Image

Genotyping Market by Product, Technology, Application - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Genotyping Assay Market Size and Forecasts 2024-2034: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User - Product Image

Genotyping Assay Market Size and Forecasts 2024-2034: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology; Application; and End-User

  • Report
  • 203 Pages
  • Global
From
Genotyping Assay Market by Product & Services (Kits, Instruments,Bioinformatics), Technology (PCR, Sequencing, Microarray), Application (Pharmacogenomics, Animal Genetics), End User (PharmaBiotech Companies, Diagnostic Labs) - Forecast to 2029 - Product Image

Genotyping Assay Market by Product & Services (Kits, Instruments,Bioinformatics), Technology (PCR, Sequencing, Microarray), Application (Pharmacogenomics, Animal Genetics), End User (PharmaBiotech Companies, Diagnostic Labs) - Forecast to 2029

  • Report
  • 371 Pages
  • Global
From
Single Nucleotide Polymorphism (SNP) Genotyping Global Market Report 2024 - Product Image

Single Nucleotide Polymorphism (SNP) Genotyping Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.